{
  "id": 2378,
  "text": "Cancer Med 5, 1863-1872 (2016).100.Kawaguchi, R., Furukawa, N., Kobayashi, H.& Asakawa, I.Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Cancer Med 5, 1863-1872 (2016).100.Kawaguchi, R., Furukawa, N., Kobayashi, H.& Asakawa, I.Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究结果，治疗后鳞状细胞癌抗原（SCC抗原）的临界值对局部晚期宫颈癌患者的预后评估具有重要作用。较高的治疗后SCC抗原水平通常与较差的预后相关，包括较低的总体生存率（OS）和无病生存期（DFS）。因此，治疗后SCC抗原的测定可作为评估患者治疗效果和长期预后的一项重要指标。精准设定SCC抗原的临界值对于评估患者是否可能有肿瘤复发或治疗失败有明确意义。这种生物标志物的监测能够帮助医生制定更加个体化和优化的后续治疗方案，从而提高宫颈癌的治疗效果和患者的生存率。",
  "query": "根据提供的<text>内容，问题可以是：\n\n在接受放射治疗的局部晚期宫颈癌患者中，治疗后鳞状细胞癌抗原（SCC抗原）的临界值如何影响预后评估？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的<text>内容，问题可以是：\n\n在接受放射治疗的局部晚期宫颈癌患者中，治疗后鳞状细胞癌抗原（SCC抗原）的临界值如何影响预后评估？\n\n<reference text>: Cancer Med 5, 1863-1872 (2016).100.Kawaguchi, R., Furukawa, N., Kobayashi, H.& Asakawa, I.Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究结果，治疗后鳞状细胞癌抗原（SCC抗原）的临界值对局部晚期宫颈癌患者的预后评估具有重要作用。较高的治疗后SCC抗原水平通常与较差的预后相关，包括较低的总体生存率（OS）和无病生存期（DFS）。因此，治疗后SCC抗原的测定可作为评估患者治疗效果和长期预后的一项重要指标。精准设定SCC抗原的临界值对于评估患者是否可能有肿瘤复发或治疗失败有明确意义。这种生物标志物的监测能够帮助医生制定更加个体化和优化的后续治疗方案，从而提高宫颈癌的治疗效果和患者的生存率。"
}